This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Oxygen-dependent Coproporphyrinogen Oxidase (COPOX) is an enzyme of the heme biosynthetic pathway. The enzyme catalyzes the conversion of two propionate chains of the heme intermediate coproporphyrinogen-III, to vinyl groups, creating protoporphyrinogen-IX. This enzyme is a potential target for therapeutic agents and herbicides. In humans, defects in this enzyme can cause a form of porphyria, making it of interest for study in relation to this broad class of diseases. There is currently no crystal structure for this form of the enzyme. The enzyme being studied here is recombinantly expressed yeast COPOX in its apo-enzyme form. We have data from 4 crystal forms, and two of these forms are included for study here.
Showing the most recent 10 out of 167 publications